分子薬学および有機プロセス研究ジャーナル

抽象的な

Impact of Motivational Interviewing by a Pharmacist on People with Diabetes Receiving the Hepatitis B Vaccine

Zhen Huang

Hepatitis B( HepB) is an acute or habitual liver infection caused by the Hepatitis B contagion( HBV).1 In 2019, the Centers for Disease Control and Prevention( CDC) entered reports of 3192 cases of acute HBV infection in the United States, although the factual number of cases is estimated to be6.5 times the number of reported cases in any time habitual HBV infection also remains a major public health problem, with cases facing a 15- 25 trouble of premature death from cirrhosis or liver cancer and the actuality of racial and racial difference in the frequency of habitual HepB. In response, the Department of Health and Human Services (HHS) released the Viral Hepatitis National Strategic Plan for the United States 2021- 2025 to count viral hepatitis as a public health trouble. thing 1 of the strategic plan includes adding viral hepatitis vaccination uptake through disquisition and scaling of swish practices in HepB vaccination harmonious with the Advisory Committee on Immunization Practices( ACIP) recommendations.